Article Information
- Received December 4, 2023
- Revision received June 5, 2024
- Accepted July 2, 2024
- First published August 30, 2024.
- Version of record published October 9, 2024.
Author Information
- Xavier Navarri1,2,*,
- Derek N. Robertson2,*,
- Iness Charfi2,3,*,
- Florian Wünnemann2,4,
- Antônia Sâmia Fernandes do Nascimento2,4,
- Giacomo Trottier2,3,
- Sévérine Leclerc2,4,
- Gregor U. Andelfinger2,4,
- Graziella Di Cristo1,2,4,
- Louis Richer5,
- G. Bruce Pike6,
- Zdenka Pausova7,
- Graciela Piñeyro1,2,3,**, and
- Tomáš Paus1,2,8,**
- 1Department of Neuroscience, Université de Montréal, Montreal, Quebec H3T 1J4, Canada
- 2CHU Ste-Justine Research Centre, Montréal, Quebec H3T 1C5, Canada
- 3Department of Pharmacology, Université de Montréal, Montreal, Quebec H3T 1J4, Canada
- 4Department of Pediatrics, Université de Montréal, Montreal, Quebec H3T 1J4, Canada
- 5Department of Health Sciences, Université du Québec à Chicoutimi, Chicoutimi, Quebec G7H 2B1, Canada
- 6Departments of Radiology and Clinical Neurosciences, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
- 7Departments of Physiology and Nutritional Sciences, Hospital for Sick Children, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario M5G 0A4, Canada
- 8Department of Psychiatry and Addictology, Université de Montréal, Montreal, Quebec H3T 1J4, Canada
Author contributions
Author contributions: D.N.R., F.W., S.L., G.U.A., G.C., L.R., G.B.P., Z.P., G.P., and T.P. designed research; D.N.R., I.C., F.W., A.S.F.N., G.T., S.L., G.U.A., G.C., L.R., G.B.P., Z.P., G.P., and T.P. performed research; I.C., A.S.F.N., G.T., S.L., G.U.A., and T.P. contributed unpublished reagents/analytic tools; X.N., Z.P., and G.P. analyzed data; X.N., Z.P., G.P., and T.P. wrote the paper.
Disclosures
- Received December 4, 2023.
- Revision received June 5, 2024.
- Accepted July 2, 2024.
This study was supported by grants from the Canadian Institutes of Health Research (NET203021, MOP86678, PJT153010, CA7170130, MOP324876) and the Fonds d'Accélération des Collaborations en Santé (FACS-008). We thank the members of the Saguenay Youth Study cohort and their families for their participation in the project.
↵*X.N., D.N.R., and I.C. are the joint first authors.
↵**G.P. and T.P. are the joint senior authors.
The authors declare no competing financial interests.
- Correspondence should be addressed to Graciela Piñeyro at graciela.pineyro.filpo{at}umontreal.ca or Tomáš Paus at tomas.paus{at}umontreal.ca.
Funding
Canadian Government | Canadian Institutes of Health Research (CIHR)
MOP 324876; NET203021; MOP86678; PJT153010; CA7170130Fonds d'Acceleration des Collaborations en Sante
FACS-008
Other Version
- previous version (August 30, 2024).
- You are viewing the most recent version of this article.
